High‐Throughput Screening of HECT E3 Ubiquitin Ligases Using UbFluor. Issue 3 (14th September 2017)

• Record Type: Journal Article
• Authors: Foote, Peter K.; Krist, David T.; Statsyuk, Alexander V.
• Is Part Of: Current protocols in chemical biology. Volume 9:Issue 3(2017)
• Page Start: 174
• Page End: 195
• Publication Date: 2017-09-14
• Subjects: ubiquitin -- HECT E3 ligase -- high‐throughput screen -- fluorescence polarization -- thioester; Biochemistry -- Laboratory manuals; Chemical Phenomena; Biochemistry; Periodicals; Laboratory manuals; 572.078
• DOI: 10.1002/cpch.24
• Languages: English
• ISSNs: 2160-4762

Abstract

Abstract: HECT E3 ubiquitin ligases are responsible for many human disease phenotypes and are promising drug targets; however, screening assays for HECT E3 inhibitors are inherently complex, requiring upstream E1 and E2 enzymes as well as ubiquitin, ATP, and detection reagents. Intermediate ubiquitin thioesters and a complex mixture of polyubiquitin products provide further opportunities for off‐target inhibition and increase the complexity of the assay. UbFluor is a novel ubiquitin thioester that bypasses the E1 and E2 enzymes and undergoes direct transthiolation with HECT E3 ligases. The release of fluorophore upon transthiolation allows fluorescence polarization detection of HECT E3 activity. In the presence of inhibitors, HECT E3 activity is ablated, and thus no reaction and no change in FP are observed. This assay has been adapted for high‐throughput screening of small molecules against HECT E3 ligases, and its utility has been proven in the discovery of HECT E3 ligase inhibitors. © 2017 by John Wiley & Sons, Inc.